Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. - Test2 - elhamkhani - TriplyDB

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.

http://www.wikidata.org/entity/Q42982277

about

Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use Immunogenicity of a Psoralen-Inactivated Dengue Virus Type 1 Vaccine Candidate in Mice UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.Novel treatment modalities: new platelet preparations and substitutes.Platelet transfusion: future directions.Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution.Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study.Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion.Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.Refined methods to evaluate the in vivo hemostatic function and viability of transfused human platelets in rabbit models.Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.Current concepts in platelet transfusion.Viral inactivation of fresh frozen plasma.Efforts in minimizing risk of viral transmission through viral inactivation.Additive solutions for the storage of platelets for transfusion.Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte Host platelets and, in part, neutrophils mediate lung accumulation of transfused UVB-irradiated human platelets in a mouse model of acute lung injury.Bacterial contamination of blood products: factors, options, and insights.CMV and blood transfusions.UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.In vivo and in vitro comparison of platelets stored in either synthetic media or plasma.Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment--final report.In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.One size will never fit all: the future of research in pediatric transfusion medicine.Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.Depletion of host reactive T cells by photodynamic cell purging and prevention of graft versus host disease.Bacterial contamination of cellular blood components: risks, sources and control.Bacterial contamination of platelet concentrates: where are we today?Psoralen Inactivation of Viruses: A Process for the Safe Manipulation of Viral Antigen and Nucleic Acid.Extended storage of autologous apheresis platelets in plasma.Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light.Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.

P2860

Q22330681-767C6EE5-3AC7-4611-86ED-9B8805869CB7 Q26741073-B8E6343D-7624-41FB-BB23-BAABF636D5C3 Q27490882-4C775240-6FB0-456E-83FC-47B8F08C0C8B Q30414377-A6D3B9BA-CD70-4A6E-A135-FD8E9FCEC217 Q30431256-C95F4025-458C-4037-AFB5-D92DD111C6B7 Q33338937-94A20DA2-351B-4B13-A230-B8FAD0ED9329 Q33361362-196A1D60-12E0-485B-BB05-4D566EDBF8EA Q33361940-33CF0C29-9086-42BF-98B2-F59CB0A8AE3E Q33368170-CD1BF580-CFC0-4602-A2AA-E92304E78C66 Q33368597-19A98C5E-189D-4526-9802-EB54ABE24D9F Q33369694-7E0CD0FB-8F49-4D2E-9485-9CCEC51BD0D0 Q33369830-31C034BC-A167-4477-9ADD-74002F36C728 Q33370536-F677DE06-A304-41A8-B979-9F044AA494A9 Q33371166-34165460-C0CE-4D53-83C5-0F35CD47BA9A Q33394914-58151F22-7E2C-4057-BFE4-87BB5C310C06 Q33397311-31F1ED7A-226A-4A3B-A09C-4DB93D91C5BD Q33443362-808E9E7A-05CC-4599-A9BE-1BA5DF21F4D2 Q33448189-801A4789-F1F7-45EC-9A35-C105A925E4C4 Q33560053-70974E04-F44B-4B3D-BE4D-EF1258249459 Q33992794-2F911505-0BC9-4AF8-AF6F-D9C147975F57 Q34087433-3ABE5FC2-7A96-4ABA-82FB-60B6753F6559 Q34109422-BFEB9345-1CBC-4F3D-9BE5-5E61FAB2E1CC Q34268237-B85CD944-0EFD-4AAD-B8DD-C4D2E12C1FC5 Q34427497-45D0C052-7F22-45D3-9EA5-D685B3645FC4 Q34522392-74BFBD44-F134-4DD5-8E54-1D75B28706FF Q34747507-8719F2A0-88C8-4551-83E1-F2092EBEB554 Q35095651-E160C345-0FCB-4ED2-8A72-2CAF11F762B6 Q35131632-C400A7B1-F21F-4019-8B9A-F0E52A5519E8 Q35194576-A7E93E96-A201-4B6B-9A3E-1368096116CD Q35265232-0BF0AE22-D9D9-43FE-96F1-2CECA186381D Q35535157-F2F0CFE7-9B71-436D-AFAF-BD6B8A2E5B1F Q35597052-C744D0C6-D2EB-44C5-B2C0-8F7D50B3FC3C Q35635546-55702F9E-9334-432C-BF2C-CA99AA6855ED Q35807467-86534AB7-7967-428B-84F1-254B3873B46A Q35812959-B231EBCA-1FB9-4C3B-B80E-FB3C24390EA0 Q36333651-300C1349-9DB9-40FF-B2F6-BA35308B389E Q36788224-CE973717-CA8E-4CA9-929D-7D1EF40AB015 Q37119569-6E2F1442-C945-4B6B-ADA2-5067F89442A7 Q37145046-F545A20E-96F3-4684-BAD3-4EBD5CC55F59 Q38052141-47C0CEE5-5C0D-42D2-8D67-89CE22D8B377

P2860

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.

http://www.wikidata.org/entity/Q42982277

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Photochemical inactivation of ...... -wavelength ultraviolet light.

@en

Photochemical inactivation of ...... -wavelength ultraviolet light.

@nl

type

label

Photochemical inactivation of ...... -wavelength ultraviolet light.

@en

Photochemical inactivation of ...... -wavelength ultraviolet light.

@nl

prefLabel

Photochemical inactivation of ...... -wavelength ultraviolet light.

@en

Photochemical inactivation of ...... -wavelength ultraviolet light.

@nl

P1433

Q42982277-6CCFF013-2334-4087-B919-F7C16DC1AE30

P1476

Q42982277-D11A5523-C9F5-4920-81EB-728B21F8E254

P2093

Q42982277-01279A66-3856-47F4-A0CE-905CADD7209F

Q42982277-04E2F49C-BD2F-4B39-800C-7C1F99CF1D38

Q42982277-0E9A77EC-25E6-4881-A0DE-4708D18DA838

Q42982277-136D0B54-15A4-4FF5-94EB-C4625F476A9C

Q42982277-2085E620-F86F-47E5-B025-5AA3C0124918

Q42982277-24118939-E926-4E68-8074-9B7D3D23B284

Q42982277-30DC1E87-1C28-4B21-A496-8DC393F1F990

Q42982277-50BAFA8C-1E06-41CB-B9AC-92C1A92A8FA9

Q42982277-60CFA4DB-B987-41EB-B859-244C2F869787

Q42982277-64FEEDD2-4C4A-40DA-91AE-43E130EAA378

P304

Q42982277-8BA8EA8E-A40B-4896-AFAA-5CCEE979DF8C

P31

Q42982277-11FD3F65-69F5-437F-A90A-13DF12086032

P356

Q42982277-1366D670-4380-4932-919A-BABDF63E6720

P433

Q42982277-9A4C394D-FE88-4787-AEBF-12ED7F9DA97B

P478

Q42982277-36BDA06A-5E3A-4552-862C-8F92F4B950FC

P577

Q42982277-BE2E50B1-06AA-4FFE-B74D-C50A01BAF1CD

P5875

Q42982277-D22162D7-25BB-48A2-B868-ED915FFB5F91

P698

Q42982277-393302D7-D2C0-46F1-815B-CB58F87336D9

P356

J.1537-2995.1997.37497265344.X

P1433

P1476

Photochemical inactivation of ...... -wavelength ultraviolet light.

@en

P2093

Alfonso R

http://www.w3.org/2001/XMLSchema#string

Behrman B

http://www.w3.org/2001/XMLSchema#string

Cimino GD

http://www.w3.org/2001/XMLSchema#string

Cook DN

http://www.w3.org/2001/XMLSchema#string

Corash L

http://www.w3.org/2001/XMLSchema#string

Corten L

http://www.w3.org/2001/XMLSchema#string

Damonte PB

http://www.w3.org/2001/XMLSchema#string

Dikeman R

http://www.w3.org/2001/XMLSchema#string

Dupuis K

http://www.w3.org/2001/XMLSchema#string

Fang YM

http://www.w3.org/2001/XMLSchema#string

P304

423-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1537-2995.1997.37497265344.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229859116

http://www.w3.org/2001/XMLSchema#string

P698

9111281

http://www.w3.org/2001/XMLSchema#string